Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sammy Saab

Showing results (221-230 of 340) with videos related to

Pageof 34
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 28, 2015
Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipientsSammy Saab, Adam Greenberg, Edwin Li, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 16, 2007
Postresection hepatic failure: successful treatment with liver transplantationYuichiro Otsuka, John P Duffy, Sammy Saab, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United StatesAijaz Ahmed, Stevan A Gonzalez, George Cholankeril, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 28, 2016
Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinomaKellie Young, Maria Aguilar, Robert Gish, et al.
Journal of Biomedical Science|November 15, 2002
Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1Sammy Saab, Steven P Tam, B inh N Tran, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2002
Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients?Sammy Saab, David Ly, Steven B Han, et al.
Biomedicines|June 28, 2023
Clinical Impact and Safety of Non-Target Punctures (NTP) during Portal Vein Access in TIPS ProcedureSasikorn Feinggumloon, Zachary Haber, Sammy Saab, et al.
Gastroenterology & Hepatology|March 6, 2024
Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment RegimensNikolaos T Pyrsopoulos, David Bernstein, Marcelo Kugelmas, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|August 30, 2019
Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantationRamy M Hanna, Beshoy Yanny, Farid Arman, et al.
Gastro Hep Advances|September 22, 2025
Effect of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Liver Enzymes Among Patients With Cystic Fibrosis: A Systematic Review and Meta-AnalysisTahne Vongsavath, Kyaw Min Tun, Dwaipayan Mukhopadhyay, et al.
Pageof 34

Showing results (221-230 of 340) with videos related to

Sort By:
Pageof 34
Liver International : Official Journal of the International Association for the Study of the Liver|April 28, 2015
Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipientsSammy Saab, Adam Greenberg, Edwin Li, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 16, 2007
Postresection hepatic failure: successful treatment with liver transplantationYuichiro Otsuka, John P Duffy, Sammy Saab, et al.
Hepatology (Baltimore, Md.)|March 4, 2017
Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United StatesAijaz Ahmed, Stevan A Gonzalez, George Cholankeril, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 28, 2016
Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinomaKellie Young, Maria Aguilar, Robert Gish, et al.
Journal of Biomedical Science|November 15, 2002
Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1Sammy Saab, Steven P Tam, B inh N Tran, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 11, 2002
Is it cost-effective to treat recurrent hepatitis C infection in orthotopic liver transplantation patients?Sammy Saab, David Ly, Steven B Han, et al.
Biomedicines|June 28, 2023
Clinical Impact and Safety of Non-Target Punctures (NTP) during Portal Vein Access in TIPS ProcedureSasikorn Feinggumloon, Zachary Haber, Sammy Saab, et al.
Gastroenterology & Hepatology|March 6, 2024
Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment RegimensNikolaos T Pyrsopoulos, David Bernstein, Marcelo Kugelmas, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|August 30, 2019
Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantationRamy M Hanna, Beshoy Yanny, Farid Arman, et al.
Gastro Hep Advances|September 22, 2025
Effect of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Liver Enzymes Among Patients With Cystic Fibrosis: A Systematic Review and Meta-AnalysisTahne Vongsavath, Kyaw Min Tun, Dwaipayan Mukhopadhyay, et al.
Pageof 34